Sowell Financial Services LLC Corcept Therapeutics Inc Transaction History

Sowell Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$19.97 - $24.43 $15,816 - $19,348	-792 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$23.49 - $30.56 $16,983 - $22,094	723 Added 1047.83%	792 $17,000
Q2 2020 Aug 13, 2020	SELL	$11.0 - $18.26 $55,000 - $91,300	-5,000 Reduced 98.64%	69 $1,000
Q1 2020 May 12, 2020	BUY	$10.11 - $14.04 $697 - $968	69 Added 1.38%	5,069 $60,000
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $52,050 - $73,300	5,000 New	5,000 $71,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.